Cargando…

EnGraft: a multicentre, open-label, randomised, two-arm, superiority study protocol to assess bioavailability and practicability of Envarsus® versus Advagraf™ in liver transplant recipients

BACKGROUND: Graft rejection and chronic CNI toxicity remain obstacles to organ transplant success. Current formulations of tacrolimus, such as Prograf® and Advagraf™, exhibit limitations in terms of pharmacokinetics and tolerability, related in part to suboptimal bioavailability. As dosing non-compl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wöhl, D. S., James, B., Götz, M., Brennfleck, F., Holub-Hayles, I., Mutzbauer, I., Baccar, S., Brunner, S. M., Geissler, E. K., Schlitt, H. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176804/ https://www.ncbi.nlm.nih.gov/pubmed/37170284 http://dx.doi.org/10.1186/s13063-023-07344-7

Ejemplares similares

Population pharmacokinetics and genetics of oral meltdose tacrolimus (Envarsus) in stable adult liver transplant recipients
por: Martial, Lisa C., et al.
Publicado: (2021)

Potentially serious medication errors with a new once-daily preparation of tacrolimus (Advagraf™)
por: Saif, Imran, et al.
Publicado: (2009)

Negative pressure wound therapy (NPWT) on closed incisions to prevent surgical site infection in high-risk patients in hepatopancreatobiliary surgery: study protocol for a randomized controlled trial—the NP-SSI trial
por: Brennfleck, Frank W., et al.
Publicado: (2020)

Impact of Conversion From Advagraf to Twice-Daily Generic Tacrolimus in Kidney Transplant Recipients: A Single-Center Study—A 3-Year Follow-Up
por: Godinho, Iolanda, et al.
Publicado: (2017)

Effect of delayed CNI-based immunosuppression with Advagraf® on liver function after MELD-based liver transplantation [IMUTECT]
por: Richter, Susanne, et al.
Publicado: (2014)

Impact of Converting from Immediate-Release Tacrolimus to Envarsus on BK Viremia Incidence in Kidney Transplant Patients with Rapid Metabolism
por: Towns, Graham, et al.
Publicado: (2023)

Successful auxiliary two-staged partial resection liver transplantation (ASPIRE-LTx) for end-stage liver disease to avoid small-for-size situations
por: Brunner, Stefan M., et al.
Publicado: (2021)

Semiresorbable biologic hybrid meshes for ventral abdominal hernia repair in potentially contaminated settings: lower risk of recurrence
por: Goetz, Markus, et al.
Publicado: (2022)

Clinical Characteristics, Microbiology, and Risk Factors for Mortality of Pre-Engraftment and Post-Engraftment Bloodstream Infection in Hematopoietic Stem Cell Transplantation Recipients
por: Chen, Weihao, et al.
Publicado: (2022)

Recipients with In Utero Induction of Tolerance Upregulated MHC Class I in the Engrafted Donor Skin
por: Chen, Jeng-Chang, et al.
Publicado: (2014)

Surgical Site Infections and their economic significance in hepatopancreatobiliary surgery: A retrospective incidence, cost, and reimbursement analysis in a German centre of the highest level of care
por: Brennfleck, Frank Werner, et al.
Publicado: (2020)

The Engrafting of Nerves
Publicado: (1845)

Collateral effects of the SARS-CoV-2 pandemic on oncologic surgery in Bavaria
por: Dienemann, Thomas, et al.
Publicado: (2021)

Prophylactic Trimethoprim-Sulfamethoxazole for Allogeneic Hematopoietic Stem Cell Transplant Recipients During the Pre-engraftment Period
por: Gaffney, Kelly J., et al.
Publicado: (2023)

Recipient Adipose-Derived Stem Cells Enhance Recipient Cell Engraftment and Prolong Allotransplant Survival in a Miniature Swine Hind-Limb Model
por: Kuo, Yur-Ren, et al.
Publicado: (2017)

Regulation of autoimmunity and donor cell engraftment by recipient Lyt- 2+ cells during the graft-versus-host reaction
Publicado: (1987)

Monocyte‐predominant engraftment, cytokine levels and early transplant‐related complications in pediatric hematopoietic stem cell recipients
por: Maximova, Natalia, et al.
Publicado: (2019)

Uncoupling key determinants of hematopoietic stem cell engraftment through cell-specific and temporally controlled recipient conditioning
por: Miharada, Natsumi, et al.
Publicado: (2021)

Using C-Arm X-Ray Imaging to Guide Local Reporter Probe Delivery for Tracking Stem Cell Engraftment
por: Kedziorek, Dorota A., et al.
Publicado: (2013)

Autologous stem cell rescue recipient with neutrophil tissue delivery detected prior to blood engraftment: A case report
por: Tbakhi, Bushra, et al.
Publicado: (2020)

Venetoclax or Ruxolitinib in Pre-Transplant Conditioning Lowers the Engraftment Barrier by Different Mechanisms in Allogeneic Stem Cell Transplant Recipients
por: Davis, Joanne E., et al.
Publicado: (2021)

Engraftment of Kidney Organoids In Vivo
por: Freedman, Benjamin S., et al.
Publicado: (2023)

Bioavailability and feasibility of subcutaneous 5-fluorouracil.
por: Borner, M. M., et al.
Publicado: (1993)

Direct bone marrow HSC transplantation enhances local engraftment at the expense of systemic engraftment in NSG mice
por: Futrega, Kathryn, et al.
Publicado: (2016)

Intestinal Microbiota at Engraftment Influence Acute Graft-Versus-Host Disease via the Treg/Th17 Balance in Allo-HSCT Recipients
por: Han, Lijie, et al.
Publicado: (2018)

Coronavirus Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation: Life-threating Features Within the Early Post-engraftment Phase
por: Oltolini, Chiara, et al.
Publicado: (2020)

Improving Islet Engraftment by Gene Therapy
por: Wang, Xiaojie, et al.
Publicado: (2011)

How to Improve Cord Blood Engraftment?
por: Beksac, Meral, et al.
Publicado: (2016)

MSCs: Delivery Routes and Engraftment, Cell-Targeting Strategies, and Immune Modulation
por: Kean, Thomas J., et al.
Publicado: (2013)

mTOR inhibition improves fibroblast growth factor receptor targeting in hepatocellular carcinoma
por: Scheller, T, et al.
Publicado: (2015)

Study Protocol: A Pilot Study to Determine the Safety and Efficacy of Induction-Therapy, De Novo MPA and Delayed mTOR-Inhibition in Liver Transplant Recipients with Impaired Renal Function. PATRON-Study
por: Schnitzbauer, Andreas A, et al.
Publicado: (2010)

Management of cardiopulmonary emergencies in hyperbaric medicine
por: Mutzbauer , TS, et al.
Publicado: (1998)

Tris[(1,4,7,10,13,16-hexaoxacyclooctadecane)rubidium] heptaantimonide–ammonia (1/4)
por: Mutzbauer, Fabian, et al.
Publicado: (2011)

Relationships between ablation of distinct haematopoietic cell subsets and the development of donor bone marrow engraftment following recipient pretreatment with different alkylating drugs.
por: Down, J. D., et al.
Publicado: (1994)

The Evaluation of Melatonin Effects on Mobilization and Engraftment in Autologous Hematopoietic Stem Cell Transplant Recipients; A Randomized, Double-blind and Placebo-controlled Trial
por: Kazeminia, Neda, et al.
Publicado: (2021)

Cytokines increase engraftment of human acute myeloid leukemia cells in immunocompromised mice but not engraftment of human myelodysplastic syndrome cells
por: Krevvata, Maria, et al.
Publicado: (2018)

Successful Secondary Engraftment of Pancreatic Ductal Adenocarcinoma and Cholangiocarcinoma Patient-Derived Xenografts After Previous Failed Primary Engraftment()
por: Hernandez, Matthew C., et al.
Publicado: (2018)

Preservation of epoxyeicosatrienoic acid bioavailability prevents renal allograft dysfunction and cardiovascular alterations in kidney transplant recipients
por: Duflot, Thomas, et al.
Publicado: (2021)

IL-13 signaling via IL-13Rα(2) triggers TGF-β(1)-dependent allograft fibrosis
por: Brunner, Stefan M, et al.
Publicado: (2013)

Flavonoid Bioavailability and Attempts for Bioavailability Enhancement
por: Thilakarathna, Surangi H., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_fk9r3c9bflld3ipk3v84lbn41l